Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases

Nicoline Jochmann(Charité - Universitätsmedizin Berlin), Verena Stangl(Humboldt-Universität zu Berlin), Edeltraut Garbe(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Gert Baumann(Charité - Universitätsmedizin Berlin), Karl Stangl(Charité - Universitätsmedizin Berlin)
European Heart Journal
July 4, 2005
10.1093/eurheartj/ehi397
Cited by 274

Related Papers

Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
|New England Journal of Medicine|2007|714
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
|BMJ|2017|525
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
|Annals of Internal Medicine|2007|476
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study
|BMJ|2010|375
Inhaled and Nasal Glucocorticoids and the Risks of Ocular Hypertension or Open-angle Glaucoma
|JAMA|1997|348